REQUEST A DEMO
Total
USD $0.00
Search more companies

Ananjay Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ananjay Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ananjay Pharmaceuticals Private Limited is an unlisted company, incorporated on 02/12/2014. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24232MP2014PTC033507 and registration number is 033507. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
H No-31, Shyamla Road Shyamla Hills
Bhopal; Madhya Pradesh; Postal Code: 462001

Contact Details: Purchase the Ananjay Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ananjay Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Ananjay Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
December 02, 2014
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Subsidiaries
Vitamax Healthcare Private Limited
75%
Company Performance
Financial values in the chart are available after Ananjay Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-48.6%
Total operating revenue
-48.49%
Operating profit (EBIT)
-9.81%
Net Profit (Loss) for the Period
-9.81%
Total assets
2.16%
Total equity
12.04%
Operating Profit Margin (ROS)
0.97%
Net Profit Margin
0.97%
Return on Equity (ROE)
-4.17%
Debt to Equity Ratio
343.38%
Quick Ratio
0.98%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?